Caxton Associates (UK)
CRI icon

Caxton Associates (UK)’s Carter's CRI Stock Holding History

Caxton Associates (UK)’s Portfolio CRI Stock Details CRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$797K Buy
+25,459
New +$910K 0.02% 368

Other funds holding CRI

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Quantinno Capital Management
Quantinno Capital Management New York $106B AUM 29.93% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Caxton Associates (UK)'s CRI Position: Q3 2026 in Review

Caxton Associates (UK) opened a new position in Carter's (CRI) in Q3 2026: 25,459 shares worth $797K. The stake represents 0.02% of the portfolio and ranks #368 among its holdings.

225 funds tracked by Wall St. Rank hold CRI as of Q3 2026.

  • Caxton Associates (UK) held 25,459 shares of Carter's worth $797K as of Q3 2026.
  • Carter's was a new Caxton Associates (UK) position in Q3 2026.
  • Carter's made up 0.02% of Caxton Associates (UK)'s portfolio in Q3 2026, its #368 holding.
  • 225 funds tracked by Wall St. Rank held Carter's as of Q3 2026.

Based on Caxton Associates (UK)'s 13F filing for Q3 2026, filed 13 Nov 2026.